X0708 D/A LIVE 0001573901 Origin Life Sciences, Inc. 2 RESEARCH WAY THIRD FLOOR PRINCETON NJ NEW JERSEY 08540 (609)250-6000 DELAWARE Plasma Jet Technologies, Inc. Origin, Inc. Advanced Plasma Therapies, Inc. Corporation true Michael David Preston c/o Origin Life Sciences, Inc. 2 Research Way, Third Floor Princeton NJ NEW JERSEY 08540 Executive Officer Director Chief Executive Officer David Dantzker c/o Origin Life Sciences, Inc. 2 Research Way, Third Floor Princeton NJ NEW JERSEY 08540 Executive Officer Director Chief Medical Officer John Fernandes c/o Origin Life Sciences, Inc. 2 Research Way, Third Floor Princeton NJ NEW JERSEY 08540 Executive Officer Chief Financial Officer Anthony Brampton c/o Origin Life Sciences, Inc. 2 Research Way, Third Floor Princeton NJ NEW JERSEY 08540 Director Victor Micati c/o Origin Life Sciences, Inc. 2 Research Way, Third Floor Princeton NJ NEW JERSEY 08540 Director Jerome Boda Korten c/o Origin Life Sciences, Inc. 2 Research Way, Third Floor Princeton NJ NEW JERSEY 08540 Director Biotechnology Decline to Disclose 06b true 0001213900-23-045117 2023-05-30 false true false 5000 Boustead Securities, LLC 141391 None None 6 VENTURE SUITE 395 IRVINE CA CALIFORNIA 92618 AL ALABAMA FL FLORIDA NY NEW YORK false 850000 659600 190400 Corporation and its stockholders are entering into a private placement offering of: (i) up to 425,000 shares of the Corporation's common stock, par value $0.01 per share, at a price per share of $2.00, for gross proceeds of up to $850,000. false 6 46172 0 0 While no offering proceeds are set aside for payments to the named officers or directors, it is possible that some proceeds to be used as working capital will be used indirectly for paying salaries to employees including executive officers. false Origin Life Sciences, Inc. /s/ Michael D. Preston Michael D. Preston Chief Executive Officer and Chairman 2023-06-22